Guardant Health Inc (GH)
18.88
+0.30
(+1.61%)
USD |
NASDAQ |
May 03, 16:00
18.90
+0.02
(+0.13%)
Pre-Market: 20:00
Guardant Health Cash from Financing (Quarterly): 90.57M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 90.57M |
September 30, 2023 | 3.807M |
June 30, 2023 | 383.85M |
March 31, 2023 | -0.854M |
December 31, 2022 | 2.318M |
September 30, 2022 | -19.31M |
June 30, 2022 | -172.09M |
March 31, 2022 | -0.012M |
December 31, 2021 | 3.78M |
September 30, 2021 | -5.56M |
June 30, 2021 | 4.909M |
March 31, 2021 | -69.95M |
Date | Value |
---|---|
December 31, 2020 | 1.047B |
September 30, 2020 | 0.797M |
June 30, 2020 | 361.32M |
March 31, 2020 | 1.466M |
December 31, 2019 | 3.077M |
September 30, 2019 | 6.871M |
June 30, 2019 | 355.07M |
March 31, 2019 | 2.288M |
December 31, 2018 | 250.36M |
September 30, 2018 | 0.796M |
June 30, 2018 | 40.73M |
March 31, 2018 | 1.267M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-172.09M
Minimum
Jun 2022
1.047B
Maximum
Dec 2020
105.09M
Average
3.077M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
Exact Sciences Corp | 10.04M |
Illumina Inc | -27.00M |
Delcath Systems Inc | 0.001M |
CytoSorbents Corp | 12.21M |
Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -78.73M |
Cash from Investing (Quarterly) | 663.45M |
Free Cash Flow | -345.46M |
Free Cash Flow Per Share (Quarterly) | -0.6983 |
Free Cash Flow to Equity (Quarterly) | -83.45M |
Free Cash Flow to Firm (Quarterly) | -82.80M |
Free Cash Flow Yield | -16.35% |